Day: February 21, 2023

Ibnsina Pharma (ISPH) has signed an agreement with the German BoehringerIngelheim to distribute the latter’s treatments across cardiovascular, cardio-renal-metabolic, and respiratory therapeutic areas in Egypt, according to a press release. "BoehringerIngelheim's partnership with Ibnsina will further strengthen our leadership position in Egypt and highlights our commitment towards delivering sustainable solutions and treatments to our patients,” Marianne AbouElkheir, General Manager and Head of Human Pharma at BoehringerIngelheim, LINEA, and SSA, said. Mohsen Mahgoub, Managing Director of Ibnsina Pharma, commented: "With this…

Under the patronage of H.H. Sheikh Hamed bin Zayed Al Nahyan, Member of Abu Dhabi Executive Office and Chairman of the Board of Trustees of Khalifa University, Khalifa University of Science and Technology has launched the Body Museum at its College of Medicine and Health Sciences (CMHS) main campus in Abu Dhabi. The museum is a testament to its commitment to delivering world-class education and enhancing the healthcare ecosystem through discovery and research. The Body Museum follows the unprecedented success…

Gulf Pharmaceutical Industries (Julphar), one of the largest pharmaceutical companies in the Middle East and Africa, has appointed a new CEO to drive strategic growth. Basel Ziyadeh, who has more than 25 years of experience in the healthcare sector, will succeed Essam Mohamed as CEO, who has stepped down from the role after joining in 2020, Julphar said in a statement recently. “With his wealth of experience in the industry working with top global and regional companies across the MENA…

The Department of Health – Abu Dhabi (DoH) and Perelman School of Medicine at the University of Pennsylvania (Penn Medicine) have signed a Memorandum of Understanding elevating mutual cooperation in education, research and innovation programmes. In line with the Department's efforts to boost innovation in Abu Dhabi, both parties plan to collaborate to support the development of the life sciences research ecosystem with a focus on expanding translational research capabilities to further enable new discoveries to develop into fresh approaches…

AstraZeneca has announced plans to construct sustainable offices at Dubai Science Park, a member of Tecom Group PJSC. Set to open in Q3 2023, the move is part of the biopharmaceutical giant’s global green agenda and in-line with ‘We the UAE 2031’ vision and the Year of Sustainability. The new office design, construction, and materials will meet platinum standards in Leadership in Energy and Environmental Design (LEED) set out by the US Green Building Council (USGBC). The Green Building Classification…